BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19546057)

  • 41. POEMS syndrome: update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leave It to the Prose: A Case of POEMS Syndrome.
    Samant S; Umpierrez De Reguerro A
    Cureus; 2021 Oct; 13(10):e18664. PubMed ID: 34790444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of atypical POEMS syndrome without polyneuropathy.
    Morizane R; Sasamura H; Minakuchi H; Takae Y; Kikuchi H; Yoshiya N; Hashiguchi A; Konishi K; Okamoto S; Itoh H
    Eur J Haematol; 2008 May; 80(5):452-5. PubMed ID: 18284621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.
    Gherardi RK; Bélec L; Fromont G; Divine M; Malapert D; Gaulard P; Degos JD
    Blood; 1994 May; 83(9):2587-93. PubMed ID: 8167341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. POEMS syndrome in a patient with diabetic ketoacidosis: case report and review.
    Warren KJ
    Cutis; 1998 Jun; 61(6):329-34. PubMed ID: 9640554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. POEMS Syndrome: A Case Report and Review of the Literature.
    Kanuganti D; Nagarjunakonda VS; Bandarupalli P; Gorijala VK; Konagalla VLSR; Kowtha P
    Cureus; 2022 Jul; 14(7):e27001. PubMed ID: 35989837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. POEMS syndrome, osteosclerotic myeloma and Castleman's disease: a case report.
    Bosco J; Pathmanathan R
    Aust N Z J Med; 1991 Aug; 21(4):454-6. PubMed ID: 1953537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. POEMS syndrome presentation with progressive weakness in upper and lower limbs: A case report.
    Cao CJ; Dou CY; Zhou KH; Liu JB; Lai H
    Oncol Lett; 2017 Nov; 14(5):5197-5202. PubMed ID: 29113155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical manifestation of POEMS syndrome with features of connective tissue disease.
    Eidner T; Oelzner P; Ebhardt H; Kosmehl H; Stein G; Hein G
    Clin Rheumatol; 2001; 20(1):70-2. PubMed ID: 11254247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease.
    Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Tsuneyama A; Suzuki YI; Nakamura K; Kano H; Kuwabara S
    J Neurol Sci; 2020 Jun; 413():116771. PubMed ID: 32172013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
    Cerri F; Falzone YM; Riva N; Quattrini A
    J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
    Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.
    Shindo M; Sato K; Yamamoto M; Toki Y; Hatayama M; Ito S; Ichiki K; Okamura N; Hosoki T; Ikuta K; Inamura J; Watanabe S; Torimoto Y; Kohgo Y
    Int J Hematol; 2011 Jun; 93(6):815-821. PubMed ID: 21553018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin manifestations of POEMS and AESOP syndrome in the same patient revealing plasma cell dyscrasia.
    Rongioletti F; Failla MC; Atzori L; Ferreli C
    J Cutan Pathol; 2016 Dec; 43(12):1167-1171. PubMed ID: 27531391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. POEMS syndrome in a patient with rheumatoid arthritis.
    Akagi T; Mukai T; Kodama S; Morita Y
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28775105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome.
    Ku A; Lachmann E; Tunkel R; Nagler W
    Arch Phys Med Rehabil; 1995 Jul; 76(7):692-4. PubMed ID: 7605193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. POEMS Syndrome: Presented as Idiopathic Multicentric Castleman Disease of Plasma Cell Variant for Eight Years and Dramatic Treatment with Siltuximab Followed by Autologous Peripheral Blood Stem Cell Transplantation.
    Lee YM; Choi YS; Kim JM
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes): A Case Report of a Rare Paraneoplastic Syndrome.
    Sakhuja A; Shrestha DB; Mir WAY; Gaire S; Kassem M
    Cureus; 2022 May; 14(5):e24980. PubMed ID: 35719778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
    Dispenzieri A
    Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.